BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 5:09:00 PM | Browse: 1110 | Download: 892
Publication Name World Journal of Rheumatology
Manuscript ID 2885
Country Greece
Received
2013-03-21 11:11
Peer-Review Started
2013-03-21 12:52
To Make the First Decision
2013-04-16 09:02
Return for Revision
2013-04-17 10:09
Revised
Second Decision
2013-06-03 16:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-06-04 09:40
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-06-09 13:10
Publish the Manuscript Online
2013-06-20 00:12
ISSN 2220-3214 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Rheumatology
Manuscript Type Editorial
Article Title B cell depletion in scleroderma lung disease: A promising new treatment?
Manuscript Source Invited Manuscript
All Author List Dimitrios Daoussis and Andrew P Andonopoulos
Funding Agency and Grant Number
Corresponding Author Dr. Dimitrios Daoussis, MD, Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504 Patras, Greece. jimdaoussis@hotmail.com
Key Words Rituximab; Scleroderma; Systemic sclerosis; Interstitial lung disease; Treatment
Core Tip Rituximab (RTX) may be an effective treatment for systemic sclerosis (SSc)-associated interstitial lung disease (ILD). A large scale study assessing the efficacy of RTX in SSc associated ILD is warranted. If RTX turns out to be effective, it would be a major therapeutic advance in SSc since it can be administered on a long term basis due to its acceptable safety profile.
Publish Date 2013-06-20 00:12
Citation Daoussis D, Andonopoulos AP. B cell depletion in scleroderma lung disease: A promising new treatment? World J Rheumatol 2013; 3(2): 9-11
URL http://www.wjgnet.com/2220-3214/full/v3/i2/9.htm
DOI http://dx.doi.org/10.5499/wjr.v3.i2.9
Full Article (PDF) WJR-3-9.pdf
Manuscript File 2885-Review.doc
Answering Reviewers 2885-Answering reviewers.pdf
Copyright License Agreement 2885-Copyright assignment.pdf
Peer-review Report 2885-Peer reviews.pdf
Scientific Editor Work List 2885-Scientific editor work list.doc